Target intelligence / Profile preview

Gut microbiota and host gastrointestinal environment

Molecular classification
Other
01

Overview

The gut microbiota and host gastrointestinal environment refers to the highly diverse community of microorganisms—primarily bacteria but also archaea, fungi, and viruses—that inhabit the human digestive tract, as well as the host tissues and milieu in which they reside. This ecosystem interacts extensively with the host, impacting digestion, nutrition, immune function, metabolic regulation, and even behavior through the production of bioactive metabolites and modulation of host signaling pathways. Disruption of this microbial community (dysbiosis) is associated with numerous diseases, making the gut microbiota a major focus for therapeutic and diagnostic interventions, although it is not itself a discrete molecular target.

Other names
gut microbiomegut floraintestinal microbiotagastrointestinal microbiomeGI microbiome
02

Mechanism of action

Direct modulation of microbial composition (antimicrobials, probiotics); Modulation of host immune signaling; Altering microbial metabolic output (e.g., SCFA production); Restoration of microbial diversity (FMT)

03

Biological functions

Symbiotic metabolism of dietary compoundsSynthesis of vitamins (e.g., vitamin K, B vitamins)Fermentation of undigested carbohydratesRegulation of host immune functionProtection against pathogen colonizationMaintenance of intestinal epithelial integrityModulation of host metabolic and neurobehavioral functions
04

Disease associations

Inflammation (inflammatory bowel disease, gut inflammation)Obesity and metabolic syndromeInfectionCancer (colorectal cancer risk modulation)Neurological/psychiatric disorders (gut-brain axis involvement)Autoimmune disease
05

Safety considerations

Antibiotic-associated dysbiosisOpportunistic infections (e.g., Clostridioides difficile)Risks of microbiota-based therapies (e.g., uncontrolled transfer of pathogens with FMT)Off-target immune or metabolic effects
06

Interacting drugs

Antibiotics

4 more in the full profile.

07

Biomarkers

Microbial diversity indices (e.g., Shannon index)Presence/abundance of key bacterial taxa/species (e.g., Faecalibacterium prausnitzii)Metabolites (short-chain fatty acids, bile acids, microbial-derived vitamins)Molecular profiling (metagenomics, metabolomics)

Beyond the preview

Go deeper on Gut microbiota and host gastrointestinal environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota and host gastrointestinal environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call